SCHEMBL277010

SCHEMBL277010

CCCC(C)CNCC(C)CCC

nearest known ligand 0.55

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.55
ALDH1A1 P00352 1/20 0.40
CYP3A4 P08684 1/20 0.40
LMNA P02545 1/20 0.30
ADH1B P00325 1/20 0.30
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30
ADH4 P08319 1/20 0.30
ADH7 P40394 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25602745 0.92 TSHR (0.48) TSHRALDH1A1CYP3A4ADH1BADH1C
SCHEMBL13679247 0.88
SCHEMBL7649165 0.88
SCHEMBL30994817 0.88 TSHR (0.50) TSHRALDH1A1CYP3A4
SCHEMBL17808442 0.86 TSHR (0.48) TSHRALDH1A1CYP3A4ADH1BADH1A
SCHEMBL22435850 0.85 ADH1B (0.45) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL7961729 0.84
SCHEMBL21029496 0.84 TSHR (0.46) TSHRALDH1A1CYP3A4
SCHEMBL7647461 0.84
SCHEMBL14188382 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090241-A1 NON-TRIAZINE BASED SCAVENGERS CHAMPIONX LLC (US) 2026-04-30 WO claimed
US-20260115648-A1 Non-Triazine Based Scavengers CHAMPIONX LLC (US) 2026-04-30 US claimed
WO-2026090241-A1 NON-TRIAZINE BASED SCAVENGERS CHAMPIONX LLC (US) 2026-04-30 WO disclosed
US-20260115648-A1 Non-Triazine Based Scavengers CHAMPIONX LLC (US) 2026-04-30 US disclosed
US-11548984-B2 Light- or heat-curing method and curable resin composition FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2023-01-10 US disclosed
US-10774062-B2 Photocuring method, compound and composition used therein FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2020-09-15 US disclosed
EP-3409709-B1 PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-08-19 EP disclosed
EP-3327002-B1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-08-19 EP disclosed
US-20200123324-A1 LIGHT- OR HEAT-CURING METHOD AND CURABLE RESIN COMPOSITION FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2020-04-23 US disclosed
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-01 US disclosed
EP-2675874-B1 METHOD OF LUBRICATING A DRIVELINE DEVICE LUBRIZOL CORP (US) 2019-04-10 EP disclosed
WO-1994015612-A1 ANTI-ATHEROSCLEROTIC AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1994-07-21 WO disclosed
EP-0564237-A2 Preparation of color filter and photo-setting resin therefor MITSUI TOATSU CHEMICALS, Inc. (JP) 1993-10-06 EP disclosed
EP-0562832-A1 Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use SANKYO COMPANY LIMITED (JP) 1993-09-29 EP disclosed
WO-1993017036-A1 ALKALI METAL 8,9-DEHYDROESTRONE SULFATE ESTERS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-09-02 WO disclosed
EP-0519423-A2 Phthalocyanine compounds and usage thereof MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-12-23 EP disclosed
US-4468526-A Process for the preparation of thiuram disulfides AKZONA INCORPORATED (US) 1984-08-28 US disclosed
US-4459424-A SECONDARY AMINE, CARBON DISULFIDE, METAL CONTAINING CATALYST AKZONA INCORPORATED (US) 1984-07-10 US disclosed
US-4113764-A Manufacture of N-substituted glycinonitriles BASF AKTIENGESELLSCHAFT (DE) 1978-09-12 US disclosed
US-4022815-A Manufacture of substituted glycinonitriles BASF AKTIENGESELLSCHAFT (DT) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator REV1, RER1, CBR1 TSHR 1154/4885ALDH1A1 847/4885CYP3A4 3181/4885
US-10774062-B2 Photocuring method, compound and composition used therein ESD, TMT1A, PAM TSHR 4741/4885ALDH1A1 23/4885CYP3A4 2435/4885
US-20260115648-A1 Non-Triazine Based Scavengers CBS, TST, GSS TSHR 1411/4885ALDH1A1 1085/4885CYP3A4 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.